Suppr超能文献

肺诺卡菌病十年回顾:55例病例系列

Ten Year Review of Pulmonary Nocardiosis: A Series of 55 Cases.

作者信息

Zia Khurram, Nafees Taha, Faizan Muhammad, Salam Osama, Asad Syeda Ifra, Khan Yasir A, Altaf Ahmed

机构信息

Internal Medicine, Liaquat College of Medicine and Dentistry, Karachi, PAK.

Internal Medicine, Karachi Medical and Dental College, Karachi, PAK.

出版信息

Cureus. 2019 May 26;11(5):e4759. doi: 10.7759/cureus.4759.

Abstract

Introduction Nocardiosis is a rare opportunistic bacterial infection usually seen in immunosuppressed patients. It is caused by gram-positive, aerobic actinomycetes of the Nocardia genus. The most common site of infection is lungs; but it may affect other organs or even disseminate into blood. Methods In this a 10-year retrospective review, all diagnosed cases of Pulmonary Nocardiosis in a tertiary care hospital were included. The clinical and radiological characteristics, course of complications and lifesaving interventions, and disease outcome were evaluated. Results Among the 55 identified cases, most common risk factor was chronic steroid therapy (n=38; 69.1%). Among respiratory diseases, chronic obstructive pulmonary disease (n=13; 23.6%) and tuberculosis (n=12; 21.8%) were the most common. On chest radiograph, pleural effusion (n=23; 41.8%) and consolidation (n=22; 40.0%) were the common findings. Complications were observed in 32 (58.2%) patients with septicemia and respiratory failure being the most common (n=15; 46.8% in each). Dissemination occurred in 10 (31.2%) patients. The mortality rate of Nocardia is 34.5% (n=19). Conclusion The disease burden of Nocardia is underestimated by clinicians and researchers. Pulmonary Nocardia should always be a differential diagnosis of signs of lower respiratory tract infection and must be excluded in patients not responding to treatment of chronic obstructive pulmonary disease (COPD) and pulmonary tuberculosis. Early recognition and individualized management plan can ensure successful recovery.

摘要

引言

诺卡菌病是一种罕见的机会性细菌感染,通常见于免疫抑制患者。它由诺卡菌属的革兰氏阳性需氧放线菌引起。最常见的感染部位是肺部,但也可能影响其他器官,甚至播散至血液。方法:在这项为期10年的回顾性研究中,纳入了一家三级护理医院所有确诊的肺诺卡菌病病例。评估了临床和放射学特征、并发症病程及挽救生命的干预措施以及疾病结局。结果:在55例确诊病例中,最常见的危险因素是长期使用类固醇治疗(n = 38;69.1%)。在呼吸系统疾病中,慢性阻塞性肺疾病(n = 13;23.6%)和肺结核(n = 12;21.8%)最为常见。胸部X线片上,胸腔积液(n = 23;41.8%)和实变(n = 22;40.0%)是常见表现。32例(58.2%)患者出现并发症,败血症和呼吸衰竭最为常见(各n = 15;46.8%)。10例(31.2%)患者发生播散。诺卡菌病的死亡率为34.5%(n = 19)。结论:临床医生和研究人员低估了诺卡菌病的疾病负担。肺诺卡菌病应始终作为下呼吸道感染体征的鉴别诊断,对于慢性阻塞性肺疾病(COPD)和肺结核治疗无反应的患者必须排除该病。早期识别和个体化管理方案可确保成功康复。

相似文献

1
Ten Year Review of Pulmonary Nocardiosis: A Series of 55 Cases.
Cureus. 2019 May 26;11(5):e4759. doi: 10.7759/cureus.4759.
2
Pulmonary nocardiosis: clinical experience in ten cases.
Respiration. 2001;68(4):382-8. doi: 10.1159/000050531.
3
Nocardiosis in a tertiary care hospital in saudi arabia.
J Glob Infect Dis. 2011 Apr;3(2):128-32. doi: 10.4103/0974-777X.81688.
4
A ten-year retrospective analysis of nocardiosis in a tertiary care center of South-coastal India.
Infez Med. 2021 Dec 10;29(4):600-608. doi: 10.53854/liim-2904-14. eCollection 2021.
5
Specific clinical manifestations of : A case report and literature review.
Exp Ther Med. 2016 Oct;12(4):2021-2026. doi: 10.3892/etm.2016.3571. Epub 2016 Aug 4.
7
Pulmonary nocardiosis in Chronic Obstructive Pulmonary Disease: A new clinical challenge.
Respir Med Case Rep. 2016 Mar 11;18:14-21. doi: 10.1016/j.rmcr.2016.03.004. eCollection 2016.
8
Pulmonary Nocardiosis: A Clinical Analysis of 30 Cases.
Intern Med. 2017;56(12):1485-1490. doi: 10.2169/internalmedicine.56.8163. Epub 2017 Jun 15.
10
Clinical spectrum and outcome of pulmonary nocardiosis: 5-year experience.
Lung India. 2016 Jul-Aug;33(4):398-403. doi: 10.4103/0970-2113.184873.

引用本文的文献

1
Fatal Empyema Thoracis Caused by .
Infect Drug Resist. 2025 Feb 4;18:669-678. doi: 10.2147/IDR.S501622. eCollection 2025.
2
Clinical screening of Nocardia in sputum smears based on neural networks.
Front Cell Infect Microbiol. 2023 Nov 29;13:1270289. doi: 10.3389/fcimb.2023.1270289. eCollection 2023.
3
Molecular detection of Nocardia: development and application of a real-time PCR assay in sputum and bronchoalveolar lavage fluid samples.
Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):865-872. doi: 10.1007/s10096-023-04619-4. Epub 2023 May 9.
4
A Rare Case of Chest Wall Abscess by Nocardia in a Patient With Sarcoidosis.
Cureus. 2022 Jul 12;14(7):e26769. doi: 10.7759/cureus.26769. eCollection 2022 Jul.
5
A Case of Asymptomatic Pulmonary Nocardia cyriacigeorgica Infection With Mild Diabetes Mellitus.
Cureus. 2022 Apr 11;14(4):e24023. doi: 10.7759/cureus.24023. eCollection 2022 Apr.
6
Infection in Nephrotic Syndrome Patients: Three Case Studies and A Systematic Literature Review.
Front Cell Infect Microbiol. 2022 Jan 24;11:789754. doi: 10.3389/fcimb.2021.789754. eCollection 2021.
8
Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.
Front Endocrinol (Lausanne). 2021 Mar 29;12:640998. doi: 10.3389/fendo.2021.640998. eCollection 2021.
10
Nocardiosis mimicking lung cancer in a heart transplant patient with end-stage renal disease.
Respir Med Case Rep. 2020 May 27;30:101101. doi: 10.1016/j.rmcr.2020.101101. eCollection 2020.

本文引用的文献

1
Antimicrobial susceptibility and clinical characteristics of Nocardia isolates from a tertiary care centre diagnostic laboratory in Pakistan.
J Glob Antimicrob Resist. 2018 Dec;15:219-221. doi: 10.1016/j.jgar.2018.06.021. Epub 2018 Jul 6.
2
Lung Diseases: Chronic Respiratory Infections.
Int J Mol Sci. 2018 Oct 7;19(10):3051. doi: 10.3390/ijms19103051.
4
Clinical spectrum and outcome of pulmonary nocardiosis: 5-year experience.
Lung India. 2016 Jul-Aug;33(4):398-403. doi: 10.4103/0970-2113.184873.
5
Pulmonary nocardiosis in Chronic Obstructive Pulmonary Disease: A new clinical challenge.
Respir Med Case Rep. 2016 Mar 11;18:14-21. doi: 10.1016/j.rmcr.2016.03.004. eCollection 2016.
6
An unusual case of pulmonary nocardiosis in immunocompetent patient.
Case Rep Pulmonol. 2014;2014:963482. doi: 10.1155/2014/963482. Epub 2014 Nov 17.
7
The incidence of nocardiosis at pulmonary and extra - pulmonary sites.
J Clin Diagn Res. 2013 Jul;7(7):1427-9. doi: 10.7860/JCDR/2013/5177.3152. Epub 2013 Jul 1.
8
Nocardiosis: updates and clinical overview.
Mayo Clin Proc. 2012 Apr;87(4):403-7. doi: 10.1016/j.mayocp.2011.11.016.
10
Pulmonary nocardiosis: risk factors and outcomes.
Respirology. 2007 May;12(3):394-400. doi: 10.1111/j.1440-1843.2007.01078.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验